Skip to main content
Top
Gepubliceerd in: Quality of Life Research 2/2018

17-11-2017

Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression

Auteurs: John F. Dickerson, David H. Feeny, Gregory N. Clarke, Alex L. MacMillan, Frances L. Lynch

Gepubliceerd in: Quality of Life Research | Uitgave 2/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To examine the longitudinal construct validity in the assessment of changes in depressive symptoms of widely used utility and generic HRQL instruments in teens.

Methods

392 teens enrolled in the study and completed HRQL and diagnostic measures as part of the baseline interview. HRQL measures included EuroQol (EQ-5D-3L), Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3), Quality of Well-Being Scale (QWB), Pediatric Quality of Life Inventory (PEDS-QL), RAND-36 (SF-6D), and Quality of Life in Depression Scale (QLDS). Youth completed follow-up interviews 12 weeks after baseline. Sixteen youth (4.1%) were lost to follow-up. We examined correlations between changes in HRQL instruments and the Children’s Depression Rating Scale-Revised (CDRS-R) and assessed clinically meaningful change in multi-attribute utility HRQL measures using mean change (MC) and standardized response mean (SRM) among youth showing at least moderate (20%) improvement in depression symptomology.

Results

Spearman’s correlation coefficients demonstrated moderate correlation between changes in CDRS-R and the HUI2 (r = 0.38), HUI3 (r = 0.42), EQ-5D-3L (r = 0.36), SF-6D (r = 0.39), and PEDS-QL (r = 0.39) and strong correlation between changes in CDRS-R and QWB (r = 0.52) and QLDS (r = − 0.71). Effect size results are also reported. Among multi-attribute utility measures, all showed clinically meaningful improvements in the sample of youth with depression improvement (HUI2, MC = 0.20, SRM = 0.97; HUI3, MC = 0.32, SRM = 1.17; EQ-5D-3L, MC = 0.08, SRM = 0.51; QWB, MC = 0.11, SRM = 0.86; and SF-6D, MC = 0.12, SRM = 1.02).

Conclusions

Findings support the longitudinal construct validity of included HRQL instruments for the assessment of change in depression outcomes in teens. Results of this study can help inform researchers about viable instruments to include in economic evaluations for this population.
Literatuur
1.
go back to reference Brent, D. A., & Weersing, V. R. (2008). Depressive disorders in childhood and adolescence. In M. Rutter, et al. (Eds.), Rutter’s child and adolescent psychiatry. Oxford: Blackwell Publishing Ltd. pp. 587–613. Brent, D. A., & Weersing, V. R. (2008). Depressive disorders in childhood and adolescence. In M. Rutter, et al. (Eds.), Rutter’s child and adolescent psychiatry. Oxford: Blackwell Publishing Ltd. pp. 587–613.
2.
go back to reference Lynch, F. L., & Clarke, G. N. (2006). Estimating the economic burden of depression in children and adolescents. American Journal of Preventive Medicine, 31(6 Suppl 1), S143-51.PubMed Lynch, F. L., & Clarke, G. N. (2006). Estimating the economic burden of depression in children and adolescents. American Journal of Preventive Medicine, 31(6 Suppl 1), S143-51.PubMed
3.
go back to reference Smith, J. P., & Smith, G. C. (2010). Long-term economic costs of psychological problems during childhood. Social Science and Medicine (1982), 71(1), pp. 110–115. Smith, J. P., & Smith, G. C. (2010). Long-term economic costs of psychological problems during childhood. Social Science and Medicine (1982), 71(1), pp. 110–115.
4.
go back to reference Tunis, S. R., Stryer, D. B., & Clancy, C. M. (2003). Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA, 290(12), 1624–1632.CrossRefPubMed Tunis, S. R., Stryer, D. B., & Clancy, C. M. (2003). Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA, 290(12), 1624–1632.CrossRefPubMed
5.
go back to reference Gold, M. R., et al. (1996). Cost-effectiveness in health and medicine. New York: Oxford Univeristy Press. Gold, M. R., et al. (1996). Cost-effectiveness in health and medicine. New York: Oxford Univeristy Press.
6.
go back to reference Drummond, M. (2001). Introducing economic and quality of life measurements into clinical studies. Annals of Medicine, 33(5), 344–349.CrossRefPubMed Drummond, M. (2001). Introducing economic and quality of life measurements into clinical studies. Annals of Medicine, 33(5), 344–349.CrossRefPubMed
7.
go back to reference Clarke, G. et al., (2016). Cognitive behavioral therapy in primary care for youth declining antidepressants: A randomized trial. Pediatrics. 137(5). Clarke, G. et al., (2016). Cognitive behavioral therapy in primary care for youth declining antidepressants: A randomized trial. Pediatrics. 137(5).
8.
go back to reference Emslie, G. J., Weinberg, W. A., & Mayes, T. L. (1998). Treatment of children with antidepressants: Focus on selective serotonin reuptake inhibitors. Depression and Anxiety, 8(Suppl1), 13–17.CrossRefPubMed Emslie, G. J., Weinberg, W. A., & Mayes, T. L. (1998). Treatment of children with antidepressants: Focus on selective serotonin reuptake inhibitors. Depression and Anxiety, 8(Suppl1), 13–17.CrossRefPubMed
9.
go back to reference Hansen, R. et al. (2008). Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatric Services (Washington, D. C.), 59(10), 1121–1130.CrossRef Hansen, R. et al. (2008). Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatric Services (Washington, D. C.), 59(10), 1121–1130.CrossRef
10.
go back to reference Jellinek, M. S., & Snyder, J. B. (1998). Depression and suicide in children and adolescents. Pediatrics in Review/American Academy of Pediatrics, 19(8), 255–264. Jellinek, M. S., & Snyder, J. B. (1998). Depression and suicide in children and adolescents. Pediatrics in Review/American Academy of Pediatrics, 19(8), 255–264.
11.
go back to reference Brazier, J., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 18(34), vii–viii, xiii–xxv, 1–188. Brazier, J., et al. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment Health Technol Assess (Rockv) Health Technology Assessment (Winchester, England), 18(34), vii–viii, xiii–xxv, 1–188.
12.
go back to reference Gunther, O. H., et al. (2008). The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. Journal of Affective Disorders, 105(1–3), 81–91.CrossRefPubMed Gunther, O. H., et al. (2008). The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. Journal of Affective Disorders, 105(1–3), 81–91.CrossRefPubMed
13.
go back to reference Byford, S. (2013). The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression. Journal of Mental Health (Abingdon, England), 22(2), 101–110.CrossRef Byford, S. (2013). The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression. Journal of Mental Health (Abingdon, England), 22(2), 101–110.CrossRef
14.
go back to reference Lynch, F. L., et al. (2016). Measuring health-related quality of life in teens with and without depression. Medical Care, 54(12), 1089–1097.CrossRefPubMed Lynch, F. L., et al. (2016). Measuring health-related quality of life in teens with and without depression. Medical Care, 54(12), 1089–1097.CrossRefPubMed
15.
go back to reference Brent, D., et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA, 299(8), 901–913.CrossRefPubMedPubMedCentral Brent, D., et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA, 299(8), 901–913.CrossRefPubMedPubMedCentral
16.
go back to reference March, J. S., et al. (2007). The treatment for adolescents with depression study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64(10), 1132–1143.CrossRefPubMed March, J. S., et al. (2007). The treatment for adolescents with depression study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64(10), 1132–1143.CrossRefPubMed
17.
go back to reference Clarke, G., et al. (2005). A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 888–898.CrossRefPubMed Clarke, G., et al. (2005). A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 888–898.CrossRefPubMed
18.
go back to reference Kaufman, J., et al. (1997). Schedule for Affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 980–988.CrossRefPubMed Kaufman, J., et al. (1997). Schedule for Affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 980–988.CrossRefPubMed
19.
go back to reference Poznanski, E. O., et al. (1984). Preliminary studies of the reliability and validity of the children’s depression rating scale. Journal of the American Academy of Child Psychiatry, 23(2), 191–197.CrossRefPubMed Poznanski, E. O., et al. (1984). Preliminary studies of the reliability and validity of the children’s depression rating scale. Journal of the American Academy of Child Psychiatry, 23(2), 191–197.CrossRefPubMed
20.
go back to reference Mayes, T. L., et al. (2010). Psychometric properties of the children’s depression rating scale-revised in adolescents. Journal of Child and Adolescent Psychopharmacology, 20(6), 513–516.CrossRefPubMedPubMedCentral Mayes, T. L., et al. (2010). Psychometric properties of the children’s depression rating scale-revised in adolescents. Journal of Child and Adolescent Psychopharmacology, 20(6), 513–516.CrossRefPubMedPubMedCentral
21.
go back to reference De Civita, M., et al. (2005). Evaluating health-related quality-of-life studies in paediatric populations: Some conceptual, methodological and developmental considerations and recent applications. PharmacoEconomics, 23(7), 659–685.CrossRefPubMed De Civita, M., et al. (2005). Evaluating health-related quality-of-life studies in paediatric populations: Some conceptual, methodological and developmental considerations and recent applications. PharmacoEconomics, 23(7), 659–685.CrossRefPubMed
22.
go back to reference Feeny, D., et al. (2004). Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: Group-and individual-level comparisons. Social Science and Medicine (1982), 58(4), 799–809.CrossRef Feeny, D., et al. (2004). Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: Group-and individual-level comparisons. Social Science and Medicine (1982), 58(4), 799–809.CrossRef
23.
go back to reference Feeny, D., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.CrossRefPubMed Feeny, D., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40(2), 113–128.CrossRefPubMed
24.
go back to reference Furlong, W. J., et al. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33(5), 375–384.CrossRefPubMed Furlong, W. J., et al. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33(5), 375–384.CrossRefPubMed
25.
go back to reference Torrance, G. W., et al. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702–722.PubMed Torrance, G. W., et al. (1996). Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Medical Care, 34(7), 702–722.PubMed
26.
go back to reference Essink-Bot, M. L., Stouthard, M. E., & Bonsel, G. J. (1993). Generalizability of valuations on health states collected with the EuroQolc-questionnaire. Health Economics, 2(3), 237–246.CrossRefPubMed Essink-Bot, M. L., Stouthard, M. E., & Bonsel, G. J. (1993). Generalizability of valuations on health states collected with the EuroQolc-questionnaire. Health Economics, 2(3), 237–246.CrossRefPubMed
27.
go back to reference Kaplan, R. M. (2003). The significance of quality of life in health care. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 12(Suppl 1), 3–16.CrossRef Kaplan, R. M. (2003). The significance of quality of life in health care. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 12(Suppl 1), 3–16.CrossRef
28.
go back to reference Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.CrossRefPubMed Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.CrossRefPubMed
29.
go back to reference Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33(5), 350–357.CrossRefPubMed Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33(5), 350–357.CrossRefPubMed
30.
go back to reference Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39(8), 800–812.CrossRefPubMed Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL 4.0: Reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Medical Care, 39(8), 800–812.CrossRefPubMed
31.
go back to reference Donald Sherbourne, C., et al. (2001). Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Medical Care, 39(11), 1246–1259.CrossRefPubMed Donald Sherbourne, C., et al. (2001). Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Medical Care, 39(11), 1246–1259.CrossRefPubMed
32.
go back to reference Hunt, S. M., & McKenna, S. P. (1992). The QLDS: a scale for the measurement of quality of life in depression. Health Policy (Amsterdam, Netherlands), 22(3), 307–319.CrossRef Hunt, S. M., & McKenna, S. P. (1992). The QLDS: a scale for the measurement of quality of life in depression. Health Policy (Amsterdam, Netherlands), 22(3), 307–319.CrossRef
34.
go back to reference Grootendorst, P., Feeny, D., & Furlong, W. (2000). Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Medical Care, 38(3), 290–299.CrossRefPubMed Grootendorst, P., Feeny, D., & Furlong, W. (2000). Health Utilities Index Mark 3: Evidence of construct validity for stroke and arthritis in a population health survey. Medical Care, 38(3), 290–299.CrossRefPubMed
35.
go back to reference Horsman, J., et al. (2003). The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54.CrossRefPubMedPubMedCentral Horsman, J., et al. (2003). The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54.CrossRefPubMedPubMedCentral
36.
go back to reference Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes, 1, 4.CrossRefPubMedPubMedCentral Walters, S. J., & Brazier, J. E. (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes, 1, 4.CrossRefPubMedPubMedCentral
37.
go back to reference Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(6), 1523–1532.CrossRef Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 14(6), 1523–1532.CrossRef
38.
go back to reference Feeny, D., et al. (2005). A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. Journal of Clinical Epidemiology, 58(2), 138–141.CrossRefPubMed Feeny, D., et al. (2005). A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. Journal of Clinical Epidemiology, 58(2), 138–141.CrossRefPubMed
39.
go back to reference Marra, C. A., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine (1982), 60(7), 1571–1582.CrossRef Marra, C. A., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine (1982), 60(7), 1571–1582.CrossRef
40.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd edn.). New Jersey: Lawrence Erlbaum Associates. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd edn.). New Jersey: Lawrence Erlbaum Associates.
41.
go back to reference Pyne, J. M., et al. (2003). Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. Journal of Affective Disorders, 76(1–3), 237–247.CrossRefPubMed Pyne, J. M., et al. (2003). Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. Journal of Affective Disorders, 76(1–3), 237–247.CrossRefPubMed
42.
go back to reference Sapin, C., et al. (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes, 2, 20.CrossRefPubMedPubMedCentral Sapin, C., et al. (2004). Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes, 2, 20.CrossRefPubMedPubMedCentral
43.
go back to reference Wiebe, S., et al. (2003). Comparative responsiveness of generic and specific quality-of-life instruments. Journal of Clinical Epidemiology, 56(1), 52–60.CrossRefPubMed Wiebe, S., et al. (2003). Comparative responsiveness of generic and specific quality-of-life instruments. Journal of Clinical Epidemiology, 56(1), 52–60.CrossRefPubMed
44.
go back to reference Turner, N., et al. (2013). A comparison of four different approaches to measuring health utility in depressed patients. Health and Quality of Life Outcomes, 11, 81.CrossRefPubMedPubMedCentral Turner, N., et al. (2013). A comparison of four different approaches to measuring health utility in depressed patients. Health and Quality of Life Outcomes, 11, 81.CrossRefPubMedPubMedCentral
46.
go back to reference Wille, N., et al. (2010). Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 19(6), 875–886.CrossRef Wille, N., et al. (2010). Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 19(6), 875–886.CrossRef
47.
go back to reference Mihalopoulos, C., et al. (2014). Assessing outcomes for cost-utility analysis in depression: Comparison of five multi-attribute utility instruments with two depression-specific outcome measures. The British Journal of Psychiatry: The Journal of Mental Science, 205(5), 390–397.CrossRef Mihalopoulos, C., et al. (2014). Assessing outcomes for cost-utility analysis in depression: Comparison of five multi-attribute utility instruments with two depression-specific outcome measures. The British Journal of Psychiatry: The Journal of Mental Science, 205(5), 390–397.CrossRef
Metagegevens
Titel
Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression
Auteurs
John F. Dickerson
David H. Feeny
Gregory N. Clarke
Alex L. MacMillan
Frances L. Lynch
Publicatiedatum
17-11-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1728-9

Andere artikelen Uitgave 2/2018

Quality of Life Research 2/2018 Naar de uitgave